CYTEK BIOSCIENCES, INC. Operating Income
CYTEK BIOSCIENCES, INC. (CTKB) reported Operating Income of -$11.40 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Income Statement
us-gaap:OperatingIncomeLoss · last filed 2026-08-05
- CYTEK BIOSCIENCES, INC. operating income (loss) for the quarter ending 2026-06-30 was -$11.40M.
- CYTEK BIOSCIENCES, INC. operating income (loss) for the quarter ending 2026-03-31 was -$18.46M.
- CYTEK BIOSCIENCES, INC. operating income (loss) for the quarter ending 2025-12-31 was -$5.59M, a 287.34% decline year-over-year.
- CYTEK BIOSCIENCES, INC. operating income (loss) for the quarter ending 2025-09-30 was -$9.19M.
- CYTEK BIOSCIENCES, INC. operating income (loss) for fiscal 2025 was -$40.38M.
- CYTEK BIOSCIENCES, INC. operating income (loss) for fiscal 2024 was -$20.52M.
- CYTEK BIOSCIENCES, INC. operating income (loss) for fiscal 2023 was -$27.84M.
- CYTEK BIOSCIENCES, INC. operating income (loss) for fiscal 2022 was -$1.80M, a 119.70% decline from fiscal 2021.
| Period end | Operating Income (Loss) 3 month | Operating Income (Loss) 6 month | Operating Income (Loss) 6 month as first filed | Operating Income (Loss) 9 month | Operating Income (Loss) 12 month |
|---|---|---|---|---|---|
| 2026-06-30 | -$11.40M 10-Q · filed 2026-08-05 | -$29.86M 10-Q · filed 2026-08-05 | -$35.46M derived: sum of 3 quarters · filed 2026-08-05 | -$44.65M derived: sum of 4 quarters · filed 2026-08-05 | |
| 2026-03-31 | -$18.46M 10-Q · filed 2026-05-07 | -$24.06M derived: sum of 2 quarters · filed 2026-05-07 | -$33.25M derived: sum of 3 quarters · filed 2026-05-07 | -$43.87M derived: sum of 4 quarters · filed 2026-08-05 | |
| 2025-12-31 | -$5.59M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | -$14.79M derived: sum of 2 quarters · filed 2026-02-26 | -$25.41M derived: sum of 3 quarters · filed 2026-08-05 | -$40.38M 10-K · filed 2026-02-26 | |
| 2025-09-30 | -$9.19M 10-Q · filed 2025-11-05 | -$19.82M derived: sum of 2 quarters · filed 2026-08-05 | -$34.79M 10-Q · filed 2025-11-05 | -$31.80M derived: sum of 4 quarters · filed 2026-08-05 | |
| 2025-06-30 | -$10.62M 10-Q · filed 2026-08-05 | -$25.60M 10-Q · filed 2026-08-05 | -$22.61M derived: sum of 3 quarters · filed 2026-08-05 | -$26.86M derived: sum of 4 quarters · filed 2026-08-05 | |
| 2025-03-31 | -$14.97M 10-Q · filed 2026-05-07 | -$11.99M derived: sum of 2 quarters · filed 2026-05-07 | -$16.24M derived: sum of 3 quarters · filed 2026-05-07 | -$24.76M derived: sum of 4 quarters · filed 2026-05-07 | |
| 2024-12-31 | $2.99M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | -$1.26M derived: sum of 2 quarters · filed 2026-02-26 | -$9.79M derived: sum of 3 quarters · filed 2026-02-26 | -$20.52M 10-K · filed 2026-02-26 | |
| 2024-09-30 | -$4.25M 10-Q · filed 2025-11-05 | -$12.78M derived: sum of 2 quarters · filed 2025-11-05 | -$23.51M 10-Q · filed 2025-11-05 | -$23.65M derived: sum of 4 quarters · filed 2026-02-26 | |
| 2024-06-30 | -$8.53M 10-Q · filed 2025-08-06 | -$19.26M 10-Q · filed 2025-08-06 | -$19.40M derived: sum of 3 quarters · filed 2026-02-26 | -$25.82M derived: sum of 4 quarters · filed 2026-02-26 | |
| 2024-03-31 | -$10.73M 10-Q · filed 2025-05-08 | -$10.87M derived: sum of 2 quarters · filed 2026-02-26 | -$17.29M derived: sum of 3 quarters · filed 2026-02-26 | -$26.42M derived: sum of 4 quarters · filed 2026-02-26 | |
| 2023-12-31 | -$137.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | -$6.56M derived: sum of 2 quarters · filed 2026-02-26 | -$15.68M derived: sum of 3 quarters · filed 2026-02-26 | -$27.84M 10-K · filed 2026-02-26 | |
| 2023-09-30 | -$6.42M 10-Q · filed 2024-11-07 | -$15.55M derived: sum of 2 quarters · filed 2024-11-07 | -$27.71M 10-Q · filed 2024-11-07 | -$27.63M derived: sum of 4 quarters · filed 2025-02-28 | |
| 2023-06-30 | -$9.13M 10-Q · filed 2024-08-06 | -$21.29M 10-Q · filed 2024-08-06 | -$21.20M derived: sum of 3 quarters · filed 2025-02-28 | -$19.84M derived: sum of 4 quarters · filed 2025-02-28 | |
| 2023-03-31 | -$12.16M 10-Q · filed 2024-05-08 | -$12.08M derived: sum of 2 quarters · filed 2025-02-28 | -$10.72M derived: sum of 3 quarters · filed 2025-02-28 | -$11.61M derived: sum of 4 quarters · filed 2025-02-28 | |
| 2022-12-31 | $84.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-28 | $1.44M derived: sum of 2 quarters · filed 2025-02-28 | $553.00K derived: sum of 3 quarters · filed 2025-02-28 | -$1.80M 10-K · filed 2025-02-28 | |
| 2022-09-30 | $1.36M 10-Q · filed 2023-11-14 | $469.00K derived: sum of 2 quarters · filed 2023-11-14 | -$1.89M 10-Q · filed 2023-11-14 | -$571.00K derived: sum of 4 quarters · filed 2024-03-13 | |
| 2022-06-30 | -$891.00K 10-Q · filed 2023-08-08 | -$3.25M 10-Q · filed 2023-08-08 | -$1.93M derived: sum of 3 quarters · filed 2024-03-13 | $966.00K derived: sum of 4 quarters · filed 2024-03-13 | |
| 2022-03-31 | -$2.36M 10-Q · filed 2023-05-09 | -$1.04M derived: sum of 2 quarters · filed 2024-03-13 | $1.86M derived: sum of 3 quarters · filed 2024-03-13 | $5.67M derived: sum of 4 quarters · filed 2024-03-13 | |
| 2021-12-31 | $1.32M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-13 | $4.21M derived: sum of 2 quarters · filed 2024-03-13 | $8.03M derived: sum of 3 quarters · filed 2024-03-13 | $9.16M 10-K · filed 2024-03-13 | |
| 2021-09-30 | $2.90M 10-Q · filed 2022-11-09 | $6.71M derived: sum of 2 quarters · filed 2022-11-09 | $7.84M 10-Q · filed 2022-11-09 | $15.72M derived: sum of 4 quarters · filed 2023-03-01 | |
| 2021-06-30 | $3.81M 10-Q · filed 2022-08-10 | -$4.94M 10-Q · filed 2022-08-10 | $4.94M 10-Q · filed 2021-09-03 | $12.82M derived: sum of 3 quarters · filed 2023-03-01 | $19.53M derived: sum of 4 quarters · filed 2023-03-01 |
| 2021-03-31 | $1.13M 10-Q · filed 2022-05-12 | $9.01M derived: sum of 2 quarters · filed 2023-03-01 | $15.72M derived: sum of 3 quarters · filed 2023-03-01 | $15.50M derived: sum of 4 quarters · filed 2023-03-01 | |
| 2020-12-31 | $7.88M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-01 | $14.59M derived: sum of 2 quarters · filed 2023-03-01 | $14.37M derived: sum of 3 quarters · filed 2023-03-01 | $13.66M 10-K · filed 2023-03-01 | |
| 2020-09-30 | $6.71M 10-Q · filed 2021-11-12 | $6.49M derived: sum of 2 quarters · filed 2021-11-12 | $5.78M 10-Q · filed 2021-11-12 | ||
| 2020-06-30 | -$218.00K 10-Q · filed 2021-09-03 | -$928.00K 10-Q · filed 2021-09-03 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | United States | $0.491B | -3.95 |
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| EyePoint, Inc. (EYPT) | United States | $0.314B | -3.96 |
| Quanterix Corp (QTRX) | United States | $0.150B | -1.65 |
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |
| Seer, Inc. (SEER) | United States | $0.104B | -1.34 |
| Precipio, Inc. (PRPO) | United States | $0.043B | -36.70 |
| HARVARD BIOSCIENCE INC (HBIO) | United States | $0.037B | -2.70 |
| Bionano Genomics, Inc. (BNGO) | United States | $0.020B | -0.42 |
| ASTROTECH Corp (ASTC) | United States | $0.013B |